Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321

Watchlist Manager
Shenzhen Chipscreen Biosciences Co Ltd Logo
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Watchlist
Price: 19.34 CNY -0.21%
Market Cap: 7.9B CNY
Have any thoughts about
Shenzhen Chipscreen Biosciences Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Shenzhen Chipscreen Biosciences Co Ltd

Revenue
656.2m CNY
Cost of Revenue
-90.3m CNY
Gross Profit
566m CNY
Operating Expenses
-588.3m CNY
Operating Income
-22.3m CNY
Other Expenses
-48m CNY
Net Income
-70.3m CNY

Income Statement
Shenzhen Chipscreen Biosciences Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
148
N/A
142
-4%
157
+10%
181
+15%
174
-4%
181
+4%
202
+12%
231
+14%
270
+17%
312
+16%
342
+10%
360
+5%
430
+20%
460
+7%
463
+1%
490
+6%
530
+8%
532
+0%
556
+4%
543
-2%
524
-4%
548
+5%
584
+7%
656
+12%
Gross Profit
Cost of Revenue
(6)
(8)
(8)
(9)
(7)
(11)
(12)
(14)
(14)
(18)
(19)
(20)
(22)
(29)
(34)
(38)
(30)
(41)
(47)
(51)
(57)
(71)
(79)
(90)
Gross Profit
142
N/A
135
-5%
149
+11%
172
+15%
167
-3%
171
+2%
191
+12%
217
+14%
256
+18%
294
+15%
323
+10%
340
+5%
409
+20%
431
+5%
430
0%
452
+5%
500
+11%
491
-2%
508
+4%
491
-3%
467
-5%
477
+2%
506
+6%
566
+12%
Operating Income
Operating Expenses
(114)
(110)
(120)
(136)
(155)
(162)
(179)
(198)
(235)
(285)
(335)
(374)
(394)
(406)
(421)
(456)
(483)
(498)
(594)
(590)
(636)
(627)
(571)
(588)
Selling, General & Administrative
(80)
(79)
(84)
(88)
(107)
(115)
(130)
(149)
(161)
(201)
(235)
(270)
(285)
(293)
(299)
(307)
(316)
(331)
(364)
(361)
(368)
(370)
(367)
(388)
Research & Development
(43)
(42)
(45)
(52)
(51)
(55)
(65)
(69)
(91)
(107)
(115)
(126)
(125)
(141)
(148)
(167)
(156)
(180)
(250)
(246)
(258)
(270)
(210)
(207)
Depreciation & Amortization
(4)
(1)
0
0
(3)
0
0
0
(6)
0
0
0
(13)
0
0
0
(23)
0
0
0
(25)
0
0
0
Other Operating Expenses
13
12
9
4
6
8
16
21
24
22
15
22
28
27
26
18
11
14
20
17
15
13
7
6
Operating Income
28
N/A
24
-14%
29
+19%
36
+23%
11
-69%
9
-19%
12
+32%
20
+65%
21
+5%
9
-58%
(12)
N/A
(34)
-178%
15
N/A
25
+62%
8
-67%
(5)
N/A
17
N/A
(7)
N/A
(86)
-1 161%
(98)
-15%
(169)
-72%
(150)
+11%
(65)
+56%
(22)
+66%
Pre-Tax Income
Interest Income Expense
4
4
4
5
11
17
21
20
16
14
10
9
7
2
4
6
(0)
(6)
280
270
(23)
263
(35)
(40)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
0
0
289
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
Total Other Income
(1)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(4)
(4)
(3)
(1)
(0)
(0)
(0)
(1)
(0)
0
0
1
Pre-Tax Income
32
N/A
28
-13%
32
+14%
41
+26%
21
-49%
25
+20%
31
+27%
38
+21%
36
-5%
22
-39%
(4)
N/A
(29)
-614%
19
N/A
23
+24%
10
-58%
0
-95%
15
+3 272%
(13)
N/A
194
N/A
172
-12%
97
-43%
113
+16%
(101)
N/A
(62)
+39%
Net Income
Tax Provision
(1)
(0)
(1)
(4)
(1)
(2)
(1)
(1)
(5)
(4)
(1)
(3)
3
3
0
2
(2)
(6)
(46)
(46)
(48)
(46)
(7)
(9)
Income from Continuing Operations
31
28
31
37
19
23
31
37
31
19
(5)
(32)
22
26
10
2
13
(19)
148
125
49
67
(108)
(70)
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
5
8
44
43
40
36
0
0
Net Income (Common)
31
N/A
28
-11%
31
+11%
37
+20%
19
-47%
23
+19%
31
+32%
37
+21%
31
-16%
19
-40%
(5)
N/A
(32)
-558%
22
N/A
26
+16%
10
-62%
4
-59%
17
+337%
(11)
N/A
192
N/A
168
-13%
89
-47%
103
+16%
(108)
N/A
(70)
+35%
EPS (Diluted)
0.09
N/A
0.07
-22%
0.07
N/A
0.09
+29%
0.05
-44%
0.06
+20%
0.08
+33%
0.09
+13%
0.08
-11%
0.04
-50%
-0.02
N/A
-0.08
-300%
0.05
N/A
0.06
+20%
0.02
-67%
0.01
-50%
0.04
+300%
-0.02
N/A
0.48
N/A
0.42
-13%
0.22
-48%
0.26
+18%
-0.26
N/A
-0.17
+35%

See Also

Discover More